Search Within

Achim Jungbluth

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (39)
  2. Meeting Abstract (27)
Groups
  1. Department of Pathology and Laboratory Medicine (66)
  2. Human Oncology and Pathogenesis Program (66)
  3. GSK Faculty (65)
  4. Tow Center for Developmental Oncology (TCDO) (54)
  5. Department of Medicine (44)
  6. Solid Tumor Oncology Division (40)

More Groups

People
  1. Marc Ladanyi (51)
  2. Denise Frosina (26)
  3. Cristina Antonescu (21)
  4. Ryma Benayed (20)
  5. Natasha Rekhtman (13)
  6. Sarah Chiang (11)

More People

Years
  1. 2025 (1)
  2. 2024 (3)
  3. 2023 (1)
  4. 2022 (5)
  5. 2021 (6)
  6. 2020 (8)

More Years

Publications
  1. Modern Pathology (23)
  2. Laboratory Investigation (9)
  3. American Journal of Surgical Pathology (6)
  4. Clinical Cancer Research (4)
  5. Journal of Thoracic Oncology (3)
  6. Cancer Discovery (2)

More Publications

Publishers
  1. Nature Research (23)
  2. Nature Publishing Group (12)
  3. American Association for Cancer Research (7)
  4. Lippincott Williams & Wilkins (6)
  5. Elsevier Inc. (5)
  6. American Society of Clinical Oncology (3)

More Publishers

Results (66)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • JAK2/PD-L1/PD-L2 (9p24.1) amplified renal cell carcinoma: Implications for clinical management
    Meeting Abstract

    Gupta, S.; Cheville, J.; Jungbluth, A.; Zhang, Y.; Zhang, L.; Chen, Y. B.; Tickoo, S.; Fine, S.; Gopalan, A.; Al-Ahmadie, H.; more...
    Laboratory Investigation (2019)

    Fulltext@MSK | Save
  • Patient-driven discovery, therapeutic targeting, and post-clinical validation of a novel AKT1 fusion-driven cancer
    Journal Article

    Slotkin, E. K.; Diolaiti, D.; Shukla, N. N.; Dela Cruz, F. S.; Clark, J. J.; Gundem, G.; Yellapantula, V. D.; Levine, M. F.; You, D.; Ma, P.; more...
    Cancer Discovery (2019)

    Fulltext@MSK | Save
  • Novel PLAG1 gene rearrangement distinguishes a subset of uterine myxoid leiomyosarcoma from other uterine myxoid mesenchymal tumors
    Journal Article

    Arias-Stella, J. A. 3rd; Benayed, R.; Oliva, E.; Young, R. H.; Hoang, L. N.; Lee, C. H.; Jungbluth, A. A.; Frosina, D.; Soslow, R. A.; Antonescu, C. R.; more...
    American Journal of Surgical Pathology (2019)

    Fulltext@MSK | Save
  • VISTA is highly expressed in malignant pleural mesothelioma (MPM) and independent of PD-L1 expression
    Meeting Abstract

    Zauderer, M.; Muller, S.; Lai, W.; Ni, A.; Jungbluth, A.; Ginsberg, M.; Daly, R.; Hellmann, M.; Ladanyi, M.; Sauter, J.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Integrative molecular characterization of malignant pleural mesothelioma
    Journal Article

    Hmeljak, J.; Sanchez-Vega, F.; Hoadley, K. A.; Shih, J.; Stewart, C.; Heiman, D.; Tarpey, P.; Danilova, L.; Drill, E.; Gibb, E. A.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • YES1 amplification is a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomics
    Journal Article

    Fan, P. D.; Narzisi, G.; Jayaprakash, A. D.; Venturini, E.; Robine, N.; Smibert, P.; Germer, S.; Yu, H. A.; Jordan, E. J.; Paik, P. K.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2018)

    Fulltext@MSK | Save
  • Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas
    Journal Article

    Geyer, F. C.; Li, A.; Papanastasiou, A. D.; Smith, A.; Selenica, P.; Burke, K. A.; Edelweiss, M.; Wen, H. C.; Piscuoglio, S.; Schultheis, A. M.; more...
    Nature Communications (2018)

    Fulltext@MSK | Save
  • NTRK fusions define a novel uterine sarcoma subtype with features of fibrosarcoma
    Journal Article

    Chiang, S.; Cotzia, P.; Hyman, D. M.; Drilon, A.; Tap, W. D.; Zhang, L.; Hechtman, J. F.; Frosina, D.; Jungbluth, A. A.; Murali, R.; more...
    American Journal of Surgical Pathology (2018)

    Fulltext@MSK | Save
  • Pulmonary BRG1 (SMARCA4)-deficient undifferentiated neoplasms represent an exceptionally aggressive type of sarcomatoid carcinoma: Clinicopathologic and genomic evidence supports a link to non-small cell carcinoma
    Meeting Abstract

    Montecalvo, J.; Alex, D.; Ptashkin, R.; Ni, A.; Sauter, J. L.; Chang, J.; Jungbluth, A.; Beras, A.; Namakydoust, A.; Rudin, C.; more...
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Prominent expression of the negative immune checkpoint regulator VISTA in malignant pleural mesothelioma (MPM)
    Meeting Abstract

    Muller, S.; Zauderer, M.; Desmeules, P.; Jungbluth, A.; Fayad, M.; Frosina, D.; Ni, A.; Ladanyi, M.; Sauter, J. L.
    Modern Pathology (2018)

    Fulltext@MSK | Save